Imai E - Search Results

1

Histoculture drug response assay, a possible examination system for predicting the antitumor effect of aromatase inhibitors in patients with breast cancer.

Nakamura J, Imai E, Yoshihama M, Sasano H, Kubota T. Nakamura J, et al. Among authors: imai e. Anticancer Res. 1998 Jan-Feb;18(1A):125-8. Anticancer Res. 1998. PMID: 9568066

2

General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.

Arisawa H, Imai E, Fujise N, Fukui K, Masunaga H. Arisawa H, et al. Among authors: imai e. Arzneimittelforschung. 2002;52(1):14-20. doi: 10.1055/s-0031-1299850. Arzneimittelforschung. 2002. PMID: 11838269

3

Genotoxicity of genetic recombinant human erythropoietin in a novel test system.

Yajima N, Kurata Y, Imai E, Sawai T, Takeshita Y. Yajima N, et al. Among authors: imai e. Mutagenesis. 1993 May;8(3):231-6. doi: 10.1093/mutage/8.3.231. Mutagenesis. 1993. PMID: 8332085

4

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.

Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Yasuda H, et al. Among authors: imai e. Hepatology. 1996 Sep;24(3):636-42. doi: 10.1053/jhep.1996.v24.pm0008781336. Hepatology. 1996. PMID: 8781336

5

Pretreatment with a deleted form of hepatocyte growth factor (dHGF) prevents the mortality of plasma-loss-induced hypovolemic shock in rats.

Arisawa H, Fukui K, Imai E, Yamashita Y, Iga Y, Masunaga H. Arisawa H, et al. Among authors: imai e. Shock. 2001 Dec;16(6):438-43. doi: 10.1097/00024382-200116060-00006. Shock. 2001. PMID: 11770041

6

Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries.

Masunaga H, Fujise N, Shiota A, Ogawa H, Sato Y, Imai E, Yasuda H, Higashio K. Masunaga H, et al. Among authors: imai e. Eur J Pharmacol. 1998 Jan 26;342(2-3):267-79. doi: 10.1016/s0014-2999(97)01485-4. Eur J Pharmacol. 1998. PMID: 9548396

7

General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects.

Arisawa H, Fukui K, Imai E, Fujise N, Masunaga H. Arisawa H, et al. Among authors: imai e. Arzneimittelforschung. 2002;52(4):225-32. doi: 10.1055/s-0031-1299885. Arzneimittelforschung. 2002. PMID: 12040964 Clinical Trial.

8

Renal anemia in polycystic kidney disease mouse.

Masunaga H, Hirabayashi M, Takahira R, Imai E, Kawanishi G. Masunaga H, et al. Among authors: imai e. J Vet Med Sci. 1991 Aug;53(4):621-7. doi: 10.1292/jvms.53.621. J Vet Med Sci. 1991. PMID: 1834204

9

Reduction of monocrotaline-induced hepatic injury by deleted variant of hepatocyte growth factor (dHGF) in rats.

Yamashita Y, Fujise N, Imai E, Masunaga H. Yamashita Y, et al. Among authors: imai e. Liver. 2002 Aug;22(4):302-7. doi: 10.1034/j.1600-0676.2002.01643.x. Liver. 2002. PMID: 12296963

10

[Effects of cianidanol (KB-53) on experimental liver injury in mice--histopathological, histochemical and enzyme-histochemical studies].

Tajima S, Takebe H, Sato I, Ikeda Y, Imai E, Ito K, Nose T. Tajima S, et al. Among authors: imai e. Nihon Yakurigaku Zasshi. 1983 Jun;81(6):519-28. Nihon Yakurigaku Zasshi. 1983. PMID: 6311698 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results